











Tata Digital (Tata Sons)
Tata 1mg franchisees generate revenue primarily from the sale of prescription medicines (Rx), over-the-counter (OTC) medications, and wellness products through their physical pharmacy outlets. The franchise operates as a retail pharmacy unit under the Tata 1mg brand, leveraging Tata Digital's e-commerce and logistics infrastructure. Franchisees may also earn from front-end FMCG categories and Tata 1mg private-label products. Revenue is generated through a margin on product sales; royalty payments to the parent company are structured at 3% of turnover. The parent company also operates Tata 1mg's digital (online pharmacy) business as a separate channel, which is not part of the franchisee's contract scope.
Tata 1mg franchisees operate within a centralized procurement and supply chain managed by Tata Digital. The parent company controls inventory distribution through its logistics network, and franchisees receive stock at parent-determined wholesale costs. This model ensures consistent product availability and quality control across outlets, but also means franchisees cannot source independently or negotiate input costs. Margin structure and inventory handling protocols (including unsold stock responsibility) are determined by the parent company as part of the franchise agreement.
Pharmacy retail demand is relatively stable and non-seasonal compared to discretionary categories, as essential medicines and health products are purchased year-round. However, seasonal spikes occur during monsoon and winter months when respiratory and seasonal illnesses increase, and during major festival periods when wellness products see higher demand. Urban pharmacies typically benefit from steady footfall in residential and commercial areas, though location-specific factors significantly influence individual outlet performance. Tata 1mg was founded in 2015 and has grown to become a significant player in India's digital and retail pharmacy space under Tata Digital's backing. The brand has expanded from its e-commerce origins into physical retail franchise partnerships. India's pharmacy retail sector continues to grow due to rising healthcare awareness and increasing access to affordable medicines. Exact current store count for franchised outlets is not publicly confirmed, limiting precise visibility into franchise expansion trajectory.
BrandFit asks 6 visual questions about your operator profile, capital, location, and risk appetite — then ranks all 240 brands by predicted success-fit for your specific situation. shows up where it actually fits, not just where it can afford.
Run BrandFit on my situationSelect the category to assign these 0 photos to:
According to FRANticc's verified franchise database, Tata 1mg requires a minimum investment of ₹10 L in a 250+ sqft commercial space under a Tata 1mg Pharmacy model. Tata 1mg operates 220 outlets across India, established in 2015. Data confidence: Reported. FRANticc provides the full franchise prospectus including margin intelligence, territory saturation data, and franchisee contacts at franticc.com.
Tata 1mg is a Health & Wellness brand operating in India. This page is the editorial franchise profile, covering operating format, investment range, store distribution, and side-by-side comparisons with peer brands. The data is independent — FRANticc never accepts payment from brands to influence coverage.
Compare Tata 1mg with other franchise opportunities on FRANticc — India's Franchise Discovery Platform. FRANticc tracks 225+ franchise brands across 14 industries with source-verified investment data, multi-source corroboration scoring, and territory saturation mapping.
Premium tools available for Tata 1mg: Margin Intelligence with channel economics breakdown, Territory Saturation Checker (find the 5 nearest outlets to any location), Franchisee Connect (talk to existing Tata 1mg operators), Legal Vault (regulatory history, directors, compliance records), and dynamic pricing based on data quality score. Visit franticc.com/brands/tata-1mg.html for the full interactive prospectus.